Cargando…

Belatacept in kidney transplant patients with systemic lupus erythematosus

OBJECTIVES: Lupus nephritis (LN) requires renal replacement therapy in 10%–30% of patients. About 30% of these patients receive a kidney transplant. Belatacept is a second-generation, selective, T-cell co-stimulator blocker (inhibits cytotoxic, T-lymphocyte antigen 4, CTLA-4) used as an alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrión-Barberà, Irene, Fajardo, Melissa, Danias, George, Tsapepas, Demetra, Gartshteyn, Yevgeniya, Fernandez, Hilda, Askanase, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928461/
https://www.ncbi.nlm.nih.gov/pubmed/31908816
http://dx.doi.org/10.1136/lupus-2019-000355